The Medical Genome Reference Bank contains whole genome and phenotype data of 2570 healthy elderly.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
23 01 2020
Historique:
received: 21 07 2019
accepted: 13 12 2019
entrez: 25 1 2020
pubmed: 25 1 2020
medline: 25 4 2020
Statut: epublish

Résumé

Population health research is increasingly focused on the genetic determinants of healthy ageing, but there is no public resource of whole genome sequences and phenotype data from healthy elderly individuals. Here we describe the first release of the Medical Genome Reference Bank (MGRB), comprising whole genome sequence and phenotype of 2570 elderly Australians depleted for cancer, cardiovascular disease, and dementia. We analyse the MGRB for single-nucleotide, indel and structural variation in the nuclear and mitochondrial genomes. MGRB individuals have fewer disease-associated common and rare germline variants, relative to both cancer cases and the gnomAD and UK Biobank cohorts, consistent with risk depletion. Age-related somatic changes are correlated with grip strength in men, suggesting blood-derived whole genomes may also provide a biologic measure of age-related functional deterioration. The MGRB provides a broadly applicable reference cohort for clinical genetics and genomic association studies, and for understanding the genetics of healthy ageing.

Identifiants

pubmed: 31974348
doi: 10.1038/s41467-019-14079-0
pii: 10.1038/s41467-019-14079-0
pmc: PMC6978518
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

435

Subventions

Organisme : NIA NIH HHS
ID : U19 AG062682
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG029824
Pays : United States
Organisme : Medical Research Council
ID : MC_QA137853
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_12028
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_17228
Pays : United Kingdom

Références

Timmers, P. R. et al. Genomics of 1 million parent lifespans implicates novel pathways and common diseases and distinguishes survival chances. Elife 8, e39856 (2019).
pubmed: 30642433 pmcid: 6333444 doi: 10.7554/eLife.39856
Pilling, L. C. et al. Human longevity: 25 genetic loci associated in 389,166 UK biobank participants. Aging 9, 2504–2520 (2017).
pubmed: 29227965 pmcid: 5764389 doi: 10.18632/aging.101334
Deelen, J. et al. A meta-analysis of genome-wide association studies identifies multiple longevity genes. Nat. Commun. 10, 3669 (2019).
pubmed: 31413261 pmcid: 6694136 doi: 10.1038/s41467-019-11558-2
Erikson, G. A. et al. Whole-genome sequencing of a healthy aging cohort. Cell 165, 1002–1011 (2016).
pubmed: 27114037 pmcid: 4860090 doi: 10.1016/j.cell.2016.03.022
Genovese, G. et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N. Engl. J. Med. 371, 2477–2487 (2014).
pubmed: 25426838 pmcid: 4290021 doi: 10.1056/NEJMoa1409405
Jaiswal, S. et al. Age-related clonal hematopoiesis associated with adverse outcomes. N. Engl. J. Med. 371, 2488–2498 (2014).
pubmed: 25426837 pmcid: 4306669 doi: 10.1056/NEJMoa1408617
Visscher, P. M. et al. 10 years of GWAS discovery: biology, function, and translation. Am. J. Hum. Genet. 101, 5–22 (2017).
pubmed: 28686856 pmcid: 5501872 doi: 10.1016/j.ajhg.2017.06.005
Zuk, O. et al. Searching for missing heritability: designing rare variant association studies. Proc. Natl. Acad. Sci. USA 111, E455–E464 (2014).
pubmed: 24443550 doi: 10.1073/pnas.1322563111 pmcid: 24443550
Zuk, O., Hechter, E., Sunyaev, S. R. & Lander, E. S. The mystery of missing heritability: genetic interactions create phantom heritability. Proc. Natl. Acad. Sci. USA 109, 1193–1198 (2012).
pubmed: 22223662 doi: 10.1073/pnas.1119675109 pmcid: 22223662
Li, D., Lewinger, J. P., Gauderman, W. J., Murcray, C. E. & Conti, D. Using extreme phenotype sampling to identify the rare causal variants of quantitative traits in association studies. Genet. Epidemiol. 35, 790–799 (2011).
pubmed: 21922541 pmcid: 4238184 doi: 10.1002/gepi.20628
Lacaze, P. The Medical Genome Reference Bank: a whole-genome data resource of 4,000 healthy elderly individuals. Rationale and cohort design. Eur. J. Hum. Genet. 27, 308–316 (2018).
pubmed: 30353151 pmcid: 6336775 doi: 10.1038/s41431-018-0279-z
McNeil, J. J. et al. Baseline characteristics of participants in the ASPREE (ASPirin in Reducing Events in the Elderly) Study. J. Gerontol. A Biol. Sci. Med. Sci. 72, 1586–1593 (2017).
pubmed: 28329340 pmcid: 5861878 doi: 10.1093/gerona/glw342
45 and Up Study Collaborators et al. Cohort profile: the 45 and up study. Int. J. Epidemiol. 37, 941–947 (2008).
doi: 10.1093/ije/dym184
Zook, J. M. et al. Integrating human sequence data sets provides a resource of benchmark SNP and indel genotype calls. Nat. Biotechnol. 32, 246–251 (2014).
pubmed: 24531798 doi: 10.1038/nbt.2835
Telenti, A. et al. Deep sequencing of 10,000 human genomes. Proc. Natl. Acad. Sci. USA 113, 11901–11906 (2016).
pubmed: 27702888 doi: 10.1073/pnas.1613365113
Lek, M. et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature 536, 285–291 (2016).
pubmed: 27535533 pmcid: 5018207 doi: 10.1038/nature19057
Walsh, R. et al. Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples. Genet. Med. 19, 192–203 (2017).
pubmed: 27532257 doi: 10.1038/gim.2016.90
Kalia, S. S. et al. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2. 0): a policy statement of the American College of Medical Genetics and Genomics. Genet. Med. 19, 249–255 (2016).
pubmed: 27854360 doi: 10.1038/gim.2016.190
Chen, R. et al. Analysis of 589,306 genomes identifies individuals resilient to severe Mendelian childhood diseases. Nat. Biotechnol. 34, 531–538 (2016).
pubmed: 27065010 doi: 10.1038/nbt.3514
Langsted, A., Nordestgaard, B. G., Benn, M., Tybjærg-Hansen, A. & Kamstrup, P. R. PCSK9 R46L loss-of-function mutation reduces Lipoprotein (a), LDL cholesterol, and risk of aortic valve stenosis. J. Clin. Endocrinol. Metab. 101, 3281–3287 (2016).
pubmed: 27218270 doi: 10.1210/jc.2016-1206
Wood, A. R. et al. Defining the role of common variation in the genomic and biological architecture of adult human height. Nat. Genet. 46, 1173 (2014).
pubmed: 25282103 pmcid: 4250049 doi: 10.1038/ng.3097
Young, A. L., Challen, G. A., Birmann, B. M. & Druley, T. E. Clonal haematopoiesis harbouring AML-associated mutations is ubiquitous in healthy adults. Nat. Commun. 7, 12484 (2016).
pubmed: 27546487 pmcid: 4996934 doi: 10.1038/ncomms12484
van den Akker, E. B. et al. Uncompromised 10-year survival of oldest old carrying somatic mutations in DNMT3A and TET2. Blood 127, 1512–1515 (2016).
pubmed: 26825711 pmcid: 4797027 doi: 10.1182/blood-2015-12-685925
Russler-Germain, D. A. et al. The R882H DNMT3A mutation associated with AML dominantly inhibits wild-type DNMT3A by blocking its ability to form active tetramers. Cancer Cell 25, 442–454 (2014).
pubmed: 24656771 pmcid: 4018976 doi: 10.1016/j.ccr.2014.02.010
Gelsi-Boyer, V. et al. Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases. J. Hematol. Oncol. 5, 12 (2012).
pubmed: 22436456 pmcid: 3355025 doi: 10.1186/1756-8722-5-12
Wachsmuth, M., Hübner, A., Li, M., Madea, B. & Stoneking, M. Age-related and heteroplasmy-related variation in human mtDNA copy number. PLoS Genet. 12, e1005939 (2016).
pubmed: 26978189 pmcid: 4792396 doi: 10.1371/journal.pgen.1005939
Kennedy, S. R., Salk, J. J., Schmitt, M. W. & Loeb, L. A. Ultra-sensitive sequencing reveals an age-related increase in somatic mitochondrial mutations that are inconsistent with oxidative damage. PLoS Genet. 9, e1003794 (2013).
pubmed: 24086148 pmcid: 3784509 doi: 10.1371/journal.pgen.1003794
von Zglinicki, T. & Martin-Ruiz, C. M. Telomeres as biomarkers for ageing and age-related diseases. Curr. Mol. Med. 5, 197–203 (2005).
doi: 10.2174/1566524053586545
Alexandrov, L. B. et al. Clock-like mutational processes in human somatic cells. Nat. Genet. 47, 1402–1407 (2015).
pubmed: 26551669 pmcid: 4783858 doi: 10.1038/ng.3441
Chainani, V. et al. Objective measures of the frailty syndrome (hand grip strength and gait speed) and cardiovascular mortality: a systematic review. Int. J. Cardiol. 215, 487–493 (2016).
pubmed: 27131770 doi: 10.1016/j.ijcard.2016.04.068
Manrai, A. K., Patel, C. J. & Ioannidis, J. P. A. In the era of precision medicine and big data, who is normal? JAMA 319, 1981–1982 (2018).
pubmed: 29710130 doi: 10.1001/jama.2018.2009
Deelen, J. et al. Genome-wide association meta-analysis of human longevity identifies a novel locus conferring survival beyond 90 years of age. Hum. Mol. Genet. 23, 4420–4432 (2014).
pubmed: 24688116 pmcid: 4103672 doi: 10.1093/hmg/ddu139
Dewey, F. E. et al. Distribution and clinical impact of functional variants in 50,726 whole-exome sequences from the DiscovEHR study. Science 354, aaf6814 (2016).
pubmed: 28008009 doi: 10.1126/science.aaf6814
Amendola, L. M. et al. Actionable exomic incidental findings in 6503 participants: challenges of variant classification. Genome Res. 25, 305–315 (2015).
pubmed: 25637381 pmcid: 4352885 doi: 10.1101/gr.183483.114
Dorschner, M. O. et al. Actionable, pathogenic incidental findings in 1,000 participants’ exomes. Am. J. Hum. Genet. 93, 631–640 (2013).
pubmed: 24055113 pmcid: 3791261 doi: 10.1016/j.ajhg.2013.08.006
Martincorena, I. et al. Tumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skin. Science 348, 880–886 (2015).
pubmed: 25999502 pmcid: 4471149 doi: 10.1126/science.aaa6806
Artandi, S. E. et al. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 406, 641–645 (2000).
pubmed: 10949306 doi: 10.1038/35020592
Chin, L. et al. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell 97, 527–538 (1999).
pubmed: 10338216 doi: 10.1016/S0092-8674(00)80762-X
Sahin, E. et al. Telomere dysfunction induces metabolic and mitochondrial compromise. Nature 470, 359–365 (2011).
pubmed: 21307849 pmcid: 3741661 doi: 10.1038/nature09787
Lee, H. W. et al. Essential role of mouse telomerase in highly proliferative organs. Nature 392, 569–574 (1998).
pubmed: 9560153 doi: 10.1038/33345
Dumble, M. et al. The impact of altered p53 dosage on hematopoietic stem cell dynamics during aging. Blood 109, 1736–1742 (2007).
pubmed: 17032926 pmcid: 1794064 doi: 10.1182/blood-2006-03-010413
Loughland, C. et al. Australian Schizophrenia Research Bank: a database of comprehensive clinical, endophenotypic and genetic data for aetiological studies of schizophrenia. Aust. NZ J. Psychiatry 44, 1029–1035 (2010).
Van der Auwera, G. A. et al. From FastQ data to high-confidence variant calls: the genome analysis toolkit best practices pipeline. Curr. Protoc. Bioinformatics 43, 11.10.1–11.10.33 (2013).
Tange, O. Gnu parallel-the command-line power tool. USENIX Magazine 36, 42–47 (2011).
Meynert, A. M., Ansari, M., FitzPatrick, D. R. & Taylor, M. S. Variant detection sensitivity and biases in whole genome and exome sequencing. BMC Bioinformatics 15, 247 (2014).
pubmed: 25038816 pmcid: 4122774 doi: 10.1186/1471-2105-15-247
Ganna, A. et al. Ultra-rare disruptive and damaging mutations influence educational attainment in the general population. Nat. Neurosci. 19, 1563–1565 (2016).
pubmed: 27694993 pmcid: 5127781 doi: 10.1038/nn.4404
Conomos, M. P., Miller, M. B., & Thornton, T. Robust inference of population structure for ancestry prediction and correction of stratification in the presence of relatedness. Genet. Epidemiol.39, 276-293 (2015).
Zheng, X. et al. A high-performance computing toolset for relatedness and principal component analysis of SNP data. Bioinformatics 28, 3326–3328 (2012).
pubmed: 23060615 pmcid: 3519454 doi: 10.1093/bioinformatics/bts606
Scrucca, L., Fop, M., Murphy, T. B. & Raftery, A. E. mclust 5: clustering, classification and density estimation using Gaussian finite mixture models. R. J. 8, 289–317 (2016).
pubmed: 27818791 pmcid: 5096736 doi: 10.32614/RJ-2016-021
Cameron, D. L. et al. GRIDSS: sensitive and specific genomic rearrangement detection using positional de Bruijn graph assembly. Genome Res. 27, 2050–2060 (2017).
pubmed: 29097403 pmcid: 5741059 doi: 10.1101/gr.222109.117
Thung, D. T. et al. Mobster: accurate detection of mobile element insertions in next generation sequencing data. Genome Biol. 15, 488 (2014).
pubmed: 25348035 pmcid: 4228151 doi: 10.1186/s13059-014-0488-x
Nagpal, S., Gibson, G. & Marigorta, U. M. Pervasive modulation of obesity risk by the environment and genomic background. Genes 9, E411 (2018).
pubmed: 30110940 doi: 10.3390/genes9080411
Machiela, M. J. & Chanock, S. J. LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants. Bioinformatics 31, 3555–3557 (2015).
pubmed: 26139635 pmcid: 4626747 doi: 10.1093/bioinformatics/btv402
Schumacher, F. R. et al. Genome-wide association study of colorectal cancer identifies six new susceptibility loci. Nat. Commun. 6, 7138 (2015).
pubmed: 26151821 pmcid: 4967357 doi: 10.1038/ncomms8138
Law, M. H. et al. Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma. Nat. Genet. 47, 987 (2015).
pubmed: 26237428 pmcid: 4557485 doi: 10.1038/ng.3373
Michailidou, K. et al. Association analysis identifies 65 new breast cancer risk loci. Nature 551, 92–94 (2017).
pubmed: 5798588 pmcid: 5798588 doi: 10.1038/nature24284
Hoffmann, T. J. et al. A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences. Cancer Discov. 5, 878–891 (2015).
pubmed: 26034056 pmcid: 4527942 doi: 10.1158/2159-8290.CD-15-0315
Warren, H. R. et al. Genome-wide association analysis identifies novel blood pressure loci and offers biological insights into cardiovascular risk. Nat. Genet. 49, 403–415 (2017).
pubmed: 28135244 pmcid: 5972004 doi: 10.1038/ng.3768
Thériault, S. et al. Polygenic contribution in individuals with early-onset coronary artery disease. Circ. Genom. Precis. Med. 11, e001849 (2018).
pubmed: 29874178 doi: 10.1161/CIRCGEN.117.001849
Lubitz, S. A. et al. Genetic risk prediction of atrial fibrillation. Circulation 135, 1311–1320 (2017).
pubmed: 27793994 doi: 10.1161/CIRCULATIONAHA.116.024143
Lambert, J. C. et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease. Nat. Genet. 45, 1452–1458 (2013).
pubmed: 24162737 pmcid: 3896259 doi: 10.1038/ng.2802
Genin, E. et al. APOE and Alzheimer disease: a major gene with semi-dominant inheritance. Mol. Psychiatry 16, 903–907 (2011).
pubmed: 21556001 pmcid: 3162068 doi: 10.1038/mp.2011.52
McLaren, W. et al. The Ensembl variant effect predictor. Genome Biol. 17, 122 (2016).
pubmed: 4893825 pmcid: 4893825 doi: 10.1186/s13059-016-0974-4
Ding, Z. et al. Estimating telomere length from whole genome sequence data. Nucleic Acids Res. 42, e75 (2014).
pubmed: 24609383 pmcid: 4027178 doi: 10.1093/nar/gku181
Cawthon, R. M. Telomere measurement by quantitative PCR. Nucleic Acids Res. 30, e47 (2002).
pubmed: 12000852 pmcid: 115301 doi: 10.1093/nar/30.10.e47
Alexandrov, L. B. et al. Signatures of mutational processes in human cancer. Nature 500, 415–421 (2013).
pubmed: 23945592 pmcid: 3776390 doi: 10.1038/nature12477
Gehring, J. S., Fischer, B., Lawrence, M. & Huber, W. SomaticSignatures: inferring mutational signatures from single-nucleotide variants. Bioinformatics 31, 3673–3675 (2015).
pubmed: 26163694 pmcid: 4817139
Wood, S. N. Stable and efficient multiple smoothing parameter estimation for generalized additive models. J. Am. Stat. Assoc. 99, 673–686 (2004).
doi: 10.1198/016214504000000980
Holm, S. A simple sequentially rejective multiple test procedure. Scand. Stat. Theory Appl. 6, 65–70 (1979).
Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Series B Stat. Methodol. 57, 289–300 (1995).

Auteurs

Mark Pinese (M)

Garvan Institute of Medical Research, Sydney, NSW, Australia.
Children's Cancer Institute, University of New South Wales, Sydney, NSW, Australia.
School of Women's and Children's Health, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia.

Paul Lacaze (P)

Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC, Australia.

Emma M Rath (EM)

Garvan Institute of Medical Research, Sydney, NSW, Australia.

Andrew Stone (A)

Garvan Institute of Medical Research, Sydney, NSW, Australia.
Children's Cancer Institute, University of New South Wales, Sydney, NSW, Australia.
School of Women's and Children's Health, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia.
St Vincent's Clinical School, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia.

Marie-Jo Brion (MJ)

Garvan Institute of Medical Research, Sydney, NSW, Australia.

Adam Ameur (A)

Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
Science for Life Laboratory, Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.

Sini Nagpal (S)

Center for Integrative Genomics, Georgia Institute of Technology, Atlanta, GA, USA.

Clare Puttick (C)

Garvan Institute of Medical Research, Sydney, NSW, Australia.

Shane Husson (S)

Garvan Institute of Medical Research, Sydney, NSW, Australia.

Dmitry Degrave (D)

Garvan Institute of Medical Research, Sydney, NSW, Australia.

Tina Navin Cristina (TN)

Sax Institute, Sydney, NSW, Australia.

Vivian F S Kahl (VFS)

Children's Medical Research Institute, Faculty of Medicine and Health, University of Sydney, Westmead, NSW, Australia.

Aaron L Statham (AL)

Garvan Institute of Medical Research, Sydney, NSW, Australia.

Robyn L Woods (RL)

Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC, Australia.

John J McNeil (JJ)

Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC, Australia.

Moeen Riaz (M)

Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC, Australia.

Margo Barr (M)

Centre for Primary Health Care and Equity, University of New South Wales, Sydney, NSW, Australia.

Mark R Nelson (MR)

Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia.

Christopher M Reid (CM)

Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
School of Public Health, Curtin University, Perth, WA, Australia.

Anne M Murray (AM)

Berman Center for Outcomes and Clinical Research, Hennepin Healthcare Research Institute, Hennepin Healthcare, Minneapolis, MN, USA.
Division of Geriatrics, Department of Medicine, Hennepin County Medical Center and University of Minnesota, Minneapolis, MN, USA.

Raj C Shah (RC)

Department of Family Medicine and Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, USA.

Rory Wolfe (R)

Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC, Australia.

Joshua R Atkins (JR)

School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, NSW, Australia.
Centre for Brain and Mental Health Research, Hunter Medical Research Institute, Newcastle, NSW, Australia.

Chantel Fitzsimmons (C)

School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, NSW, Australia.
Centre for Brain and Mental Health Research, Hunter Medical Research Institute, Newcastle, NSW, Australia.

Heath M Cairns (HM)

School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, NSW, Australia.
Centre for Brain and Mental Health Research, Hunter Medical Research Institute, Newcastle, NSW, Australia.

Melissa J Green (MJ)

School of Psychiatry, University of New South Wales, Sydney, NSW, Australia.
Neuroscience Research Australia, Sydney, NSW, Australia.

Vaughan J Carr (VJ)

School of Psychiatry, University of New South Wales, Sydney, NSW, Australia.
Neuroscience Research Australia, Sydney, NSW, Australia.
Department of Psychiatry, School of Clinical Sciences, Monash University, Melbourne, VIC, Australia.

Mark J Cowley (MJ)

Garvan Institute of Medical Research, Sydney, NSW, Australia.
Children's Cancer Institute, University of New South Wales, Sydney, NSW, Australia.
School of Women's and Children's Health, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia.

Hilda A Pickett (HA)

Children's Medical Research Institute, Faculty of Medicine and Health, University of Sydney, Westmead, NSW, Australia.

Paul A James (PA)

Parkville Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.

Joseph E Powell (JE)

UNSW Cellular Genomics Futures Institute, School of Medical Sciences, University of New South Wales, Sydney, NSW, Australia.
Garvan-Weizmann Centre for Cellular Genomics, Garvan Institute of Medical Research, Sydney, NSW, Australia.

Warren Kaplan (W)

Garvan Institute of Medical Research, Sydney, NSW, Australia.
St Vincent's Clinical School, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia.

Greg Gibson (G)

Center for Integrative Genomics, Georgia Institute of Technology, Atlanta, GA, USA.

Ulf Gyllensten (U)

Science for Life Laboratory, Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.

Murray J Cairns (MJ)

School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, NSW, Australia.
Centre for Brain and Mental Health Research, Hunter Medical Research Institute, Newcastle, NSW, Australia.

Martin McNamara (M)

Sax Institute, Sydney, NSW, Australia.

Marcel E Dinger (ME)

Garvan Institute of Medical Research, Sydney, NSW, Australia.
School of Biotechnology and Biomolecular Sciences, Faculty of Science, University of New South Wales, Sydney, NSW, Australia.

David M Thomas (DM)

Garvan Institute of Medical Research, Sydney, NSW, Australia. d.thomas@garvan.org.au.
St Vincent's Clinical School, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia. d.thomas@garvan.org.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH